Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.

Illumina, Inc. terlibat dalam pengembangan, pembuatan, dan pemasaran alat ilmu kehidupan serta sistem terintegrasi untuk analisis besar-besaran variasi genetik dan fungsinya. Perusahaan ini berkantor pusat di San Diego, California dan saat ini mempekerjakan 8.970 karyawan penuh waktu. Perusahaan ini melakukan penawaran umum perdana (IPO) pada 28 Juni 2000. Produk dan layanan perusahaan melayani pelanggan di berbagai pasar, memungkinkan adopsi solusi genomik dalam penelitian dan pengaturan klinis. Teknologi pengurutan DNA-nya didasarkan pada kimia pengurutan berbasis terminator reversibel, yang disebut sebagai biokimia pengurutan melalui sintesis. Teknologi BeadArray-nya menggabungkan butiran mikroskopis dan substrat dalam proses pembuatan untuk menghasilkan array yang dapat melakukan banyak uji coba secara bersamaan. Aplikasi pengurutannya mencakup kit pengurutan seluruh genom, yang mengurutkan seluruh genom dengan ukuran dan kompleksitas apa pun, serta kit pengurutan target ulang, yang dapat mengurutkan eksom, gen spesifik, RNA, atau daerah genomik lain yang menjadi perhatian. Pelanggannya termasuk pusat penelitian genomik, institusi akademik, laboratorium pemerintah, rumah sakit, perusahaan farmasi, bioteknologi, laboratorium diagnostik molekuler komersial, dan lainnya.

Illumina

NVIDIA

Apple

Google

Microsoft

Amazon

Broadcom

Meta Platforms

Taiwan Semiconductor

Tesla

Berkshire Hathaway

Walmart

Eli Lilly

JPMorgan

Visa

Oracle

Exxon Mobil

MasterCard

Johnson & Johnson

Palantir

SPDR S&P500 ETF

ASML

Netflix

Bank of America

AbbVie

Costco

Alibaba

Home Depot

Procter & Gamble

Cisco

Vanguard Total Stock Market ETF

Chevron

Coca-Cola

General Electric

UnitedHealth Group

Wells Fargo

Caterpillar

Morgan Stanley

AstraZeneca

Micron Technology

Goldman Sachs

American Express

Toyota

Novartis

Salesforce

Merck

T-Mobile

Philip Morris

Raytheon Technologies

Royal Bank of Canada

McDonald's

Abbott

Applied Materials

Novo Nordisk

Shopify

Shell

Intuitive Surgical

Invesco QQQ Trust

Citigroup

Lam Research

PepsiCo

Intel

Uber

Disney

QUALCOMM

Intuit

Linde PLC

Blackstone

AT&T

ServiceNow

Amgen

Verizon

NextEra Energy

Charles Schwab

Sony

Booking Holdings

BlackRock

Accenture

Texas Instruments

Danaher

Arista Networks

Banco Santander

Boeing

S&P Global

Toronto-Dominion Bank

Gilead Sciences

Pfizer

Capital One

Adobe

Unilever

Boston Scientific

TotalEnergies

Union Pacific

Lowe's

Analog Devices

Illumina Stock

About Illumina

Key Statistics